Long-Term Morbidity and Mortality in Whipple’s Disease: A Single-Center Experience Over 20 Years

References

• Marth T , MoosV, MüllerC, BiagiF, SchneiderT. Tropheryma whipplei infection and Whipple's disease. Lancet Infect. Dis.16(3), 13–22 (2016).
   PubMed Web of Science ®Google Scholar
• Biagi F , BalduzziD, DelvinoP, SchiepattiA, KlersyC, CorazzaGR. Prevalence of Whipple’s disease in north-western Italy. Eur. J. Clin. Microbiol. Infect. Dis.34(7), 1347–1348 (2015).
   PubMed Web of Science ®Google Scholar
• Relman DA , SchmidtTM, MacDermottRP, FalkowS. Identification of the uncultured bacillus of Whipple’s disease. N. Engl. J. Med.327(5), 293–301 (1992).
   PubMed Web of Science ®Google Scholar
• Paulley JW . A case of Whipple’s disease (intestinal lipodystrophy). Gastroenterology22(1), 128–133 (1952).
   PubMed Web of Science ®Google Scholar
• Feurle GE , MoosV, SchinnerlingKet al. The immune reconstitution inflammatory syndrome in whipple disease: a cohort study. Ann. Intern. Med.153(11), 710–717 (2010).
   PubMed Web of Science ®Google Scholar
• Biagi F , TrottaL, DiStefano Met al. Previous immunosuppressive therapy is a risk factor for immune reconstitution inflammatory syndrome in Whipple's disease. Dig. Liver Dis.44(10), 880–882 (2012).
   PubMedGoogle Scholar
• Marth T , RaoultD. Whipple's disease. Lancet361(9353), 239–246 (2003).
   PubMed Web of Science ®Google Scholar
• Fleming JL , WiesnerRH, ShorterRG. Whipple's disease: clinical, biochemical, and histopathologic features and assessment of treatment in 29 patients. Mayo Clin. Proc.63(6), 539–551 (1988).
   PubMed Web of Science ®Google Scholar
• Misbah SA , MapstoneNP. Whipple's disease revisited. J. Clin. Pathol.53(10), 750–755 (2000).
   PubMed Web of Science ®Google Scholar
• Schneider T , StallmachA, von HerbayA, MarthT, StroberW, ZeitzM. Treatment of refractory Whipple disease with interferon-gamma. Ann. Intern. Med.129(11), 875–877 (1998).
   PubMed Web of Science ®Google Scholar
• Lagier JC , FenollarF, LepidiH, RaoultD. Failure and relapse after treatment with trimethoprim/sulfamethoxazole in classic Whipple's disease. J. Antimicrob. Chemother.65(9), 2005–2012 (2010).
   PubMed Web of Science ®Google Scholar
• Lagier JC , FenollarF, LepidiH, RaoultD. Evidence of lifetime susceptibility to Tropheryma whipplei in patients with Whipple's disease. J. Antimicrob. Chemother.66(5), 1188–1189 (2011).
   PubMed Web of Science ®Google Scholar
• Lagier JC , FenollarF, LepidiH, GiorgiR, MillionM, RaoultD. Treatment of classic Whipple's disease: from in vitro results to clinical outcome. J. Antimicrob. Chemother.69(1), 219–227 (2014).
   PubMed Web of Science ®Google Scholar
• Martinetti M , BiagiF, BadulliCet al. The HLA alleles DRB1*13 and DQB1*06 are associated to Whipple's disease. Gastroenterology136(7), 2289–2294 (2009).
   PubMed Web of Science ®Google Scholar
• Biagi F , BadulliC, FeurleGEet al. Cytokine genetic profile in Whipple's disease. Eur. J. Clin. Microbiol. Infect. Dis.31(11), 3145–3150 (2012).
   PubMed Web of Science ®Google Scholar
• Biagi F , SchiepattiA, BadulliCet al. −295 T-to-C promoter region IL-16 gene polymorphism is associated with Whipple's disease. Eur. J. Clin. Microbiol. Infect. Dis.34(9), 1919–1921 (2015).
   PubMed Web of Science ®Google Scholar
• Biagi F , BiagiGL, CorazzaGR. What is the best therapy for Whipple's disease? Our point of view. Scand. J. Gastroenterol.52(4), 465–466 (2017).
   PubMed Web of Science ®Google Scholar
• Feurle GE , JungaNS, MarthT. Efficacy of ceftriaxone or meropenem as initial therapies in Whipple's disease. Gastroenterology138(2), 478–486 (2010).
   PubMed Web of Science ®Google Scholar
• Feurle GE , MoosV, BläkerHet al. Intravenous ceftriaxone, followed by 12 or three months of oral treatment with trimethoprim-sulfamethoxazole in Whipple's disease. J. Infect.66(3), 263–270 (2013).
   PubMed Web of Science ®Google Scholar
• Marth T , KleenN, StallmachAet al. Dysregulated peripheral and mucosal Th1/Th2 response in Whipple's disease. Gastroenterology123(5), 1468–1477 (2002).
   PubMed Web of Science ®Google Scholar
• Moos V , KunkelD, MarthTet al. Reduced peripheral and mucosal Tropheryma whipplei-specific Th1 response in patients with Whipple's disease. J. Immunol.177(3), 2015–2022 (2006).
   PubMed Web of Science ®Google Scholar
• Sulis G , VillanacciV, MissaleG, SalemmeM, CastelliF, Caligaris. Whipple's disease concomitant with candida esophagitis and subsequent Giardia lamblia coinfection. Eur. J. Gastroenterol. Hepatol.26(10), 1181–1185 (2014).
   PubMed Web of Science ®Google Scholar
• Fenollar F , LepidiH, GérolamiR, DrancourtM, RaoultD. Whipple disease associated with giardiasis. J. Infect. Dis.188(6), 828–834 (2003).
   PubMed Web of Science ®Google Scholar
• Gillen CD , CoddingtonR, MonteithPG, TaylorRH. Extraintestinal lymphoma in association with Whipple's disease. Gut34(11), 1627–1629 (1993).
   PubMed Web of Science ®Google Scholar
• Mohm J , NaumannR, SchulerU, EhningerG. Abdominal lymphomas, convulsive seizure and coma: a case of successfully treated, advanced Whipple's disease with cerebral involvement. Eur. J. Gastroenterol. Hepatol.10(10), 893–895 (1998).
   PubMed Web of Science ®Google Scholar
• Walter R , BachmannSP, SchaffnerA, RüeggR, SchoedonG. Bone marrow involvement in Whipple's disease: rarely reported, but really rare?Br. J. Haematol.112(3), 677–679 (2001).
   PubMed Web of Science ®Google Scholar
• Wang S , ErnstLM, SmithBRet al. Systemic Tropheryma whippleii infection associated with monoclonal B-cell proliferation: a helicobacter pylori-type pathogenesis? Arch. Pathol. Lab. Med. 127(12), 1619–1622 (2003).
   PubMed Web of Science ®Google Scholar
• Henriques MS , da PazAR, GaertnerABet al. Deep vein thrombosis as initial manifestation of Whipple disease. Case Rep. Gastroenterol.10(3), 640–645 (2016).
   PubMedGoogle Scholar